
Migraine Science
Tue, Sep 08, 26
Botox for Chronic Migraine: What 479 Real-World Patients Show
A 479-patient real-world study of onabotulinumtoxinA for chronic migraine found a mean reduction of 5.9 monthly headache days, with 27.3% reaching the 50% response threshold and 41.6% shedding medication overuse....
Read MoreWed, Sep 02, 26
The New Migraine Prevention Guideline: What the AAN and AHS Recommend
The American Academy of Neurology and the American Headache Society have published a joint practice guideline on migraine prevention in adults: 17 recommendations and 52 statements. It names no single...
Read MoreMigraine Research News: The Best Place to Follow New Migraine Studies Daily
Migraine research moves every week and almost none of it reaches the people who have migraine. Today in Migraine Science is a free page, updated daily, that summarizes the newest...
Read More









